A new editorial paper titled "Obesity paradox and lung cancer, metformin-based therapeutic opportunity?" has been published in Oncotarget.
Nov 15, 2023
0
0
Researchers from the Germans Trias i Pujol Research Institute (IGTP) have led a comprehensive review study on biomarkers for the often-overlooked partial remission phase of type 1 diabetes in collaboration with experts in ...
Nov 14, 2023
0
5
Canadian scientists have established for the first time a new mechanism and role for LDL in the development of type 2 diabetes, beyond its traditional role in the development of cardiovascular disease in humans.
Nov 13, 2023
0
13
A trio of University of Texas at Arlington researchers focused on patient-centered communications has found that women who felt their health concerns were listened to by their health care providers had more positive outcomes ...
Nov 7, 2023
0
0
In the largest study of its kind, researchers at Vanderbilt University Medical Center have identified unexpected alterations in the exocrine tissues of the pancreas that occur in the two major forms of diabetes, and with ...
Nov 6, 2023
0
7
New research from Boston Medical Center found that research staff who interact with patients of the same race or ethnicity increased the odds of those patients agreeing to participate in clinical studies by almost a factor ...
Oct 19, 2023
0
0
Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports.
Oct 18, 2023
0
55
UCLA-led research suggests that diabetes control can significantly improve for Latinos when a pharmacist implements an intervention that addresses these patients' barriers to medication adherence.
Sep 28, 2023
0
1
Prediabetes is a condition that precedes type 2 diabetes and increases the risk of heart attack, kidney and eye disease, and several types of cancer. There is no approved drug therapy for prediabetes. Scientists at the German ...
Sep 26, 2023
0
50
To live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only treatment, subcutaneous insulin, is burdensome—requiring regular injections or an insulin pump, continuous ...
Sep 8, 2023
0
8
